Blood:在GVHD过程中,Bhlhe40+ GM-CSF+ CD4+ T细胞促进胃肠道间接抗原提呈

2020-01-01 QQY MedSci原创

中心点:Bhlhe40是GVHD中调节CD4+ T细胞介导的GM-CSF产生和结肠病理损伤的关键转录因子。CD4+ T细胞来源的GM-CSF的产生通过促进胃肠道间接抗原递呈,将适应性与先天免疫联系起来。摘要:急性移植物抗宿主病(GVHD)的发病和死亡的主要原因是胃肠道受累,病理损伤主要是因为炎性细胞因子产生。近年来,GM-CSF被认为是一种调节胃肠道炎症的细胞因子,但是调控GM-CSF生成的转录程

中心点:

Bhlhe40是GVHD中调节CD4+ T细胞介导的GM-CSF产生和结肠病理损伤的关键转录因子。

CD4+ T细胞来源的GM-CSF的产生通过促进肠道间接抗原递呈,将适应性与先天免疫联系起来。

摘要:

急性移植物抗宿主病(GVHD)的发病和死亡的主要原因是肠道受累,病理损伤主要是因为炎性细胞因子产生。近年来,GM-CSF被认为是一种调节胃肠道炎症的细胞因子,但是调控GM-CSF生成的转录程序以及GM-CSF在该组织区域内将适应性免疫与先天免疫联系起来的机制尚未明确。

在本研究中,研究人员发信息Bhlhe40是调控GM-CSF生成的关键转录调控因子,在GVHD过程中,在胃肠道内通过CD4+T细胞介导病理损伤。此外,研究人员还发现GM-CSF既不受IL-6调控,也不受IL-23调控(IL-6和IL-10是GVHD诱导的慢性心病变的重要诱导因子),提示GM-CSF在胃肠道中构成非冗余的炎症通路。

在机制上,GM-CSF对调节性T细胞重构无不良影响,但可通过增强供体来源的树突状细胞在结肠中的激活以及这些细胞在肠系膜淋巴结中的积聚,将适应性与先天免疫联系起来。此外,GM-CSF可促进间接的同种抗原提呈,导致供体来源的T细胞在结肠中积累,并具有促炎细胞因子表型。

总而言之,Bhlhe40+ GM-CSF+ CD4+ T细胞构成了一种可促进胃肠道内间接抗原表达和病理损伤的产肠T细胞群,GM-CSF是结肠GVHD的关键调节因子,可作为改善该病的潜在治疗靶点。

原始出处:

本文系梅斯医学(MedSci)原创编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1780328, encodeId=7f311e803281b, content=<a href='/topic/show?id=ec2133867a' target=_blank style='color:#2F92EE;'>#Bhlhe40#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3386, encryptionId=ec2133867a, topicName=Bhlhe40)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI5PdY90y5Jib8FnPhCXTR2d9v3K17epNSwB2eb0vmXUldNJl2e72S4unZTAHLAojicdVSialTDFHAxA/132, createdBy=78d82500042, createdName=ms7514935887898259, createdTime=Sat Mar 28 13:37:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746935, encodeId=6a6d1e4693580, content=<a href='/topic/show?id=2103862699' target=_blank style='color:#2F92EE;'>#HE4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8626, encryptionId=2103862699, topicName=HE4)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a535877307, createdName=cqlidoudou, createdTime=Fri Aug 14 09:37:00 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864268, encodeId=5909186426823, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4325, encryptionId=f930432538, topicName=CD4)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sat Jun 13 01:37:00 CST 2020, time=2020-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668863, encodeId=64c3166886318, content=<a href='/topic/show?id=a41d5339c1' target=_blank style='color:#2F92EE;'>#CSF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5339, encryptionId=a41d5339c1, topicName=CSF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5226466702, createdName=kcb078, createdTime=Tue Aug 25 18:37:00 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1975624, encodeId=396419e562476, content=<a href='/topic/show?id=04ac8964c1' target=_blank style='color:#2F92EE;'>#HLH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8964, encryptionId=04ac8964c1, topicName=HLH)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Mon Nov 23 23:37:00 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652599, encodeId=c7bf165259966, content=<a href='/topic/show?id=5082432634' target=_blank style='color:#2F92EE;'>#CD4+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4326, encryptionId=5082432634, topicName=CD4+)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c1624305102, createdName=xuyu, createdTime=Sat Dec 12 16:37:00 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346296, encodeId=0a5c1346296ae, content=<a href='/topic/show?id=339e8332035' target=_blank style='color:#2F92EE;'>#胃肠道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83320, encryptionId=339e8332035, topicName=胃肠道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e03212, createdName=liao1619, createdTime=Fri Jan 03 11:37:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623361, encodeId=650b162336188, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55263, encryptionId=62a655263e9, topicName=抗原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f59b20519025, createdName=xiaoyeshuang, createdTime=Fri Jan 03 11:37:00 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1780328, encodeId=7f311e803281b, content=<a href='/topic/show?id=ec2133867a' target=_blank style='color:#2F92EE;'>#Bhlhe40#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3386, encryptionId=ec2133867a, topicName=Bhlhe40)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI5PdY90y5Jib8FnPhCXTR2d9v3K17epNSwB2eb0vmXUldNJl2e72S4unZTAHLAojicdVSialTDFHAxA/132, createdBy=78d82500042, createdName=ms7514935887898259, createdTime=Sat Mar 28 13:37:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746935, encodeId=6a6d1e4693580, content=<a href='/topic/show?id=2103862699' target=_blank style='color:#2F92EE;'>#HE4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8626, encryptionId=2103862699, topicName=HE4)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a535877307, createdName=cqlidoudou, createdTime=Fri Aug 14 09:37:00 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864268, encodeId=5909186426823, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4325, encryptionId=f930432538, topicName=CD4)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sat Jun 13 01:37:00 CST 2020, time=2020-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668863, encodeId=64c3166886318, content=<a href='/topic/show?id=a41d5339c1' target=_blank style='color:#2F92EE;'>#CSF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5339, encryptionId=a41d5339c1, topicName=CSF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5226466702, createdName=kcb078, createdTime=Tue Aug 25 18:37:00 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1975624, encodeId=396419e562476, content=<a href='/topic/show?id=04ac8964c1' target=_blank style='color:#2F92EE;'>#HLH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8964, encryptionId=04ac8964c1, topicName=HLH)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Mon Nov 23 23:37:00 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652599, encodeId=c7bf165259966, content=<a href='/topic/show?id=5082432634' target=_blank style='color:#2F92EE;'>#CD4+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4326, encryptionId=5082432634, topicName=CD4+)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c1624305102, createdName=xuyu, createdTime=Sat Dec 12 16:37:00 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346296, encodeId=0a5c1346296ae, content=<a href='/topic/show?id=339e8332035' target=_blank style='color:#2F92EE;'>#胃肠道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83320, encryptionId=339e8332035, topicName=胃肠道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e03212, createdName=liao1619, createdTime=Fri Jan 03 11:37:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623361, encodeId=650b162336188, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55263, encryptionId=62a655263e9, topicName=抗原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f59b20519025, createdName=xiaoyeshuang, createdTime=Fri Jan 03 11:37:00 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
    2020-08-14 cqlidoudou
  3. [GetPortalCommentsPageByObjectIdResponse(id=1780328, encodeId=7f311e803281b, content=<a href='/topic/show?id=ec2133867a' target=_blank style='color:#2F92EE;'>#Bhlhe40#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3386, encryptionId=ec2133867a, topicName=Bhlhe40)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI5PdY90y5Jib8FnPhCXTR2d9v3K17epNSwB2eb0vmXUldNJl2e72S4unZTAHLAojicdVSialTDFHAxA/132, createdBy=78d82500042, createdName=ms7514935887898259, createdTime=Sat Mar 28 13:37:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746935, encodeId=6a6d1e4693580, content=<a href='/topic/show?id=2103862699' target=_blank style='color:#2F92EE;'>#HE4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8626, encryptionId=2103862699, topicName=HE4)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a535877307, createdName=cqlidoudou, createdTime=Fri Aug 14 09:37:00 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864268, encodeId=5909186426823, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4325, encryptionId=f930432538, topicName=CD4)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sat Jun 13 01:37:00 CST 2020, time=2020-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668863, encodeId=64c3166886318, content=<a href='/topic/show?id=a41d5339c1' target=_blank style='color:#2F92EE;'>#CSF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5339, encryptionId=a41d5339c1, topicName=CSF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5226466702, createdName=kcb078, createdTime=Tue Aug 25 18:37:00 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1975624, encodeId=396419e562476, content=<a href='/topic/show?id=04ac8964c1' target=_blank style='color:#2F92EE;'>#HLH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8964, encryptionId=04ac8964c1, topicName=HLH)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Mon Nov 23 23:37:00 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652599, encodeId=c7bf165259966, content=<a href='/topic/show?id=5082432634' target=_blank style='color:#2F92EE;'>#CD4+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4326, encryptionId=5082432634, topicName=CD4+)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c1624305102, createdName=xuyu, createdTime=Sat Dec 12 16:37:00 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346296, encodeId=0a5c1346296ae, content=<a href='/topic/show?id=339e8332035' target=_blank style='color:#2F92EE;'>#胃肠道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83320, encryptionId=339e8332035, topicName=胃肠道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e03212, createdName=liao1619, createdTime=Fri Jan 03 11:37:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623361, encodeId=650b162336188, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55263, encryptionId=62a655263e9, topicName=抗原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f59b20519025, createdName=xiaoyeshuang, createdTime=Fri Jan 03 11:37:00 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
    2020-06-13 qidongfanjian
  4. [GetPortalCommentsPageByObjectIdResponse(id=1780328, encodeId=7f311e803281b, content=<a href='/topic/show?id=ec2133867a' target=_blank style='color:#2F92EE;'>#Bhlhe40#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3386, encryptionId=ec2133867a, topicName=Bhlhe40)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI5PdY90y5Jib8FnPhCXTR2d9v3K17epNSwB2eb0vmXUldNJl2e72S4unZTAHLAojicdVSialTDFHAxA/132, createdBy=78d82500042, createdName=ms7514935887898259, createdTime=Sat Mar 28 13:37:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746935, encodeId=6a6d1e4693580, content=<a href='/topic/show?id=2103862699' target=_blank style='color:#2F92EE;'>#HE4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8626, encryptionId=2103862699, topicName=HE4)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a535877307, createdName=cqlidoudou, createdTime=Fri Aug 14 09:37:00 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864268, encodeId=5909186426823, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4325, encryptionId=f930432538, topicName=CD4)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sat Jun 13 01:37:00 CST 2020, time=2020-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668863, encodeId=64c3166886318, content=<a href='/topic/show?id=a41d5339c1' target=_blank style='color:#2F92EE;'>#CSF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5339, encryptionId=a41d5339c1, topicName=CSF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5226466702, createdName=kcb078, createdTime=Tue Aug 25 18:37:00 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1975624, encodeId=396419e562476, content=<a href='/topic/show?id=04ac8964c1' target=_blank style='color:#2F92EE;'>#HLH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8964, encryptionId=04ac8964c1, topicName=HLH)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Mon Nov 23 23:37:00 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652599, encodeId=c7bf165259966, content=<a href='/topic/show?id=5082432634' target=_blank style='color:#2F92EE;'>#CD4+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4326, encryptionId=5082432634, topicName=CD4+)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c1624305102, createdName=xuyu, createdTime=Sat Dec 12 16:37:00 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346296, encodeId=0a5c1346296ae, content=<a href='/topic/show?id=339e8332035' target=_blank style='color:#2F92EE;'>#胃肠道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83320, encryptionId=339e8332035, topicName=胃肠道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e03212, createdName=liao1619, createdTime=Fri Jan 03 11:37:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623361, encodeId=650b162336188, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55263, encryptionId=62a655263e9, topicName=抗原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f59b20519025, createdName=xiaoyeshuang, createdTime=Fri Jan 03 11:37:00 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
    2020-08-25 kcb078
  5. [GetPortalCommentsPageByObjectIdResponse(id=1780328, encodeId=7f311e803281b, content=<a href='/topic/show?id=ec2133867a' target=_blank style='color:#2F92EE;'>#Bhlhe40#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3386, encryptionId=ec2133867a, topicName=Bhlhe40)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI5PdY90y5Jib8FnPhCXTR2d9v3K17epNSwB2eb0vmXUldNJl2e72S4unZTAHLAojicdVSialTDFHAxA/132, createdBy=78d82500042, createdName=ms7514935887898259, createdTime=Sat Mar 28 13:37:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746935, encodeId=6a6d1e4693580, content=<a href='/topic/show?id=2103862699' target=_blank style='color:#2F92EE;'>#HE4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8626, encryptionId=2103862699, topicName=HE4)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a535877307, createdName=cqlidoudou, createdTime=Fri Aug 14 09:37:00 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864268, encodeId=5909186426823, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4325, encryptionId=f930432538, topicName=CD4)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sat Jun 13 01:37:00 CST 2020, time=2020-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668863, encodeId=64c3166886318, content=<a href='/topic/show?id=a41d5339c1' target=_blank style='color:#2F92EE;'>#CSF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5339, encryptionId=a41d5339c1, topicName=CSF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5226466702, createdName=kcb078, createdTime=Tue Aug 25 18:37:00 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1975624, encodeId=396419e562476, content=<a href='/topic/show?id=04ac8964c1' target=_blank style='color:#2F92EE;'>#HLH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8964, encryptionId=04ac8964c1, topicName=HLH)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Mon Nov 23 23:37:00 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652599, encodeId=c7bf165259966, content=<a href='/topic/show?id=5082432634' target=_blank style='color:#2F92EE;'>#CD4+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4326, encryptionId=5082432634, topicName=CD4+)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c1624305102, createdName=xuyu, createdTime=Sat Dec 12 16:37:00 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346296, encodeId=0a5c1346296ae, content=<a href='/topic/show?id=339e8332035' target=_blank style='color:#2F92EE;'>#胃肠道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83320, encryptionId=339e8332035, topicName=胃肠道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e03212, createdName=liao1619, createdTime=Fri Jan 03 11:37:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623361, encodeId=650b162336188, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55263, encryptionId=62a655263e9, topicName=抗原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f59b20519025, createdName=xiaoyeshuang, createdTime=Fri Jan 03 11:37:00 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
    2020-11-23 循证小兵
  6. [GetPortalCommentsPageByObjectIdResponse(id=1780328, encodeId=7f311e803281b, content=<a href='/topic/show?id=ec2133867a' target=_blank style='color:#2F92EE;'>#Bhlhe40#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3386, encryptionId=ec2133867a, topicName=Bhlhe40)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI5PdY90y5Jib8FnPhCXTR2d9v3K17epNSwB2eb0vmXUldNJl2e72S4unZTAHLAojicdVSialTDFHAxA/132, createdBy=78d82500042, createdName=ms7514935887898259, createdTime=Sat Mar 28 13:37:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746935, encodeId=6a6d1e4693580, content=<a href='/topic/show?id=2103862699' target=_blank style='color:#2F92EE;'>#HE4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8626, encryptionId=2103862699, topicName=HE4)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a535877307, createdName=cqlidoudou, createdTime=Fri Aug 14 09:37:00 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864268, encodeId=5909186426823, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4325, encryptionId=f930432538, topicName=CD4)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sat Jun 13 01:37:00 CST 2020, time=2020-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668863, encodeId=64c3166886318, content=<a href='/topic/show?id=a41d5339c1' target=_blank style='color:#2F92EE;'>#CSF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5339, encryptionId=a41d5339c1, topicName=CSF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5226466702, createdName=kcb078, createdTime=Tue Aug 25 18:37:00 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1975624, encodeId=396419e562476, content=<a href='/topic/show?id=04ac8964c1' target=_blank style='color:#2F92EE;'>#HLH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8964, encryptionId=04ac8964c1, topicName=HLH)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Mon Nov 23 23:37:00 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652599, encodeId=c7bf165259966, content=<a href='/topic/show?id=5082432634' target=_blank style='color:#2F92EE;'>#CD4+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4326, encryptionId=5082432634, topicName=CD4+)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c1624305102, createdName=xuyu, createdTime=Sat Dec 12 16:37:00 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346296, encodeId=0a5c1346296ae, content=<a href='/topic/show?id=339e8332035' target=_blank style='color:#2F92EE;'>#胃肠道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83320, encryptionId=339e8332035, topicName=胃肠道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e03212, createdName=liao1619, createdTime=Fri Jan 03 11:37:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623361, encodeId=650b162336188, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55263, encryptionId=62a655263e9, topicName=抗原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f59b20519025, createdName=xiaoyeshuang, createdTime=Fri Jan 03 11:37:00 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
    2020-12-12 xuyu
  7. [GetPortalCommentsPageByObjectIdResponse(id=1780328, encodeId=7f311e803281b, content=<a href='/topic/show?id=ec2133867a' target=_blank style='color:#2F92EE;'>#Bhlhe40#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3386, encryptionId=ec2133867a, topicName=Bhlhe40)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI5PdY90y5Jib8FnPhCXTR2d9v3K17epNSwB2eb0vmXUldNJl2e72S4unZTAHLAojicdVSialTDFHAxA/132, createdBy=78d82500042, createdName=ms7514935887898259, createdTime=Sat Mar 28 13:37:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746935, encodeId=6a6d1e4693580, content=<a href='/topic/show?id=2103862699' target=_blank style='color:#2F92EE;'>#HE4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8626, encryptionId=2103862699, topicName=HE4)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a535877307, createdName=cqlidoudou, createdTime=Fri Aug 14 09:37:00 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864268, encodeId=5909186426823, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4325, encryptionId=f930432538, topicName=CD4)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sat Jun 13 01:37:00 CST 2020, time=2020-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668863, encodeId=64c3166886318, content=<a href='/topic/show?id=a41d5339c1' target=_blank style='color:#2F92EE;'>#CSF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5339, encryptionId=a41d5339c1, topicName=CSF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5226466702, createdName=kcb078, createdTime=Tue Aug 25 18:37:00 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1975624, encodeId=396419e562476, content=<a href='/topic/show?id=04ac8964c1' target=_blank style='color:#2F92EE;'>#HLH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8964, encryptionId=04ac8964c1, topicName=HLH)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Mon Nov 23 23:37:00 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652599, encodeId=c7bf165259966, content=<a href='/topic/show?id=5082432634' target=_blank style='color:#2F92EE;'>#CD4+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4326, encryptionId=5082432634, topicName=CD4+)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c1624305102, createdName=xuyu, createdTime=Sat Dec 12 16:37:00 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346296, encodeId=0a5c1346296ae, content=<a href='/topic/show?id=339e8332035' target=_blank style='color:#2F92EE;'>#胃肠道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83320, encryptionId=339e8332035, topicName=胃肠道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e03212, createdName=liao1619, createdTime=Fri Jan 03 11:37:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623361, encodeId=650b162336188, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55263, encryptionId=62a655263e9, topicName=抗原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f59b20519025, createdName=xiaoyeshuang, createdTime=Fri Jan 03 11:37:00 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1780328, encodeId=7f311e803281b, content=<a href='/topic/show?id=ec2133867a' target=_blank style='color:#2F92EE;'>#Bhlhe40#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3386, encryptionId=ec2133867a, topicName=Bhlhe40)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI5PdY90y5Jib8FnPhCXTR2d9v3K17epNSwB2eb0vmXUldNJl2e72S4unZTAHLAojicdVSialTDFHAxA/132, createdBy=78d82500042, createdName=ms7514935887898259, createdTime=Sat Mar 28 13:37:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746935, encodeId=6a6d1e4693580, content=<a href='/topic/show?id=2103862699' target=_blank style='color:#2F92EE;'>#HE4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8626, encryptionId=2103862699, topicName=HE4)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a535877307, createdName=cqlidoudou, createdTime=Fri Aug 14 09:37:00 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864268, encodeId=5909186426823, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4325, encryptionId=f930432538, topicName=CD4)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sat Jun 13 01:37:00 CST 2020, time=2020-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668863, encodeId=64c3166886318, content=<a href='/topic/show?id=a41d5339c1' target=_blank style='color:#2F92EE;'>#CSF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5339, encryptionId=a41d5339c1, topicName=CSF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5226466702, createdName=kcb078, createdTime=Tue Aug 25 18:37:00 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1975624, encodeId=396419e562476, content=<a href='/topic/show?id=04ac8964c1' target=_blank style='color:#2F92EE;'>#HLH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8964, encryptionId=04ac8964c1, topicName=HLH)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Mon Nov 23 23:37:00 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652599, encodeId=c7bf165259966, content=<a href='/topic/show?id=5082432634' target=_blank style='color:#2F92EE;'>#CD4+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4326, encryptionId=5082432634, topicName=CD4+)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c1624305102, createdName=xuyu, createdTime=Sat Dec 12 16:37:00 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346296, encodeId=0a5c1346296ae, content=<a href='/topic/show?id=339e8332035' target=_blank style='color:#2F92EE;'>#胃肠道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83320, encryptionId=339e8332035, topicName=胃肠道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e03212, createdName=liao1619, createdTime=Fri Jan 03 11:37:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623361, encodeId=650b162336188, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55263, encryptionId=62a655263e9, topicName=抗原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f59b20519025, createdName=xiaoyeshuang, createdTime=Fri Jan 03 11:37:00 CST 2020, time=2020-01-03, status=1, ipAttribution=)]

相关资讯

Blood:消化道抗原提呈细胞在alloHSCT后GVHD中的重要作用

同种异体干细胞移植仍然是治疗高危和/或晚期血液系统恶性肿瘤的基础,但仍受到移植物抗宿主病(GVHD)的限制。GVHD是由受体抗原提呈细胞(APC)与供体T细胞相互作用而引起的,T细胞分化成1型(Th1/Tc1)和17型(Th17/Tc17)致病性T细胞,导致抗原耐受性调节T细胞(Treg/Tr1)模式被破坏。1型和17型T细胞分泌对细胞因子风暴至关重要的细胞因子(如GM-CSF和IFNg),增强供

Blood:抑制Itpkb可预防和治疗GVHD

T细胞活化释放肌醇1,4,5-三磷酸(IP3),诱导细胞质钙离子(Ca2+)内流。反过来,肌醇1,4,5-三磷酸3-激酶B (Itpkb)磷酸化IP3进行负性调控,从而严格控制Ca2+流量,这对成熟T细胞的激活、分化和保护细胞死亡均至关重要。抑制Itpkb途径增加细胞内Ca2+浓度,诱导激活的T细胞凋亡,并可控制T细胞介导的自身炎症。Thangavelu等人采用遗传学和药理学方法抑制Itpkb信号

Blood:雷帕霉素治疗标准风险的急性GVHD

以临床和生物标志物为基础的工具或可识别较低风险的急性移植物抗宿主病(GVHD)人群,使其能够接受新型低强度的治疗。既往数据表明雷帕霉素或可匹敌泼尼松的标准效果。Pidala等人开展一多中心的非盲的随机化II期试验,来评估雷帕霉素对比泼尼松作为标准风险(SR,根据MN GVHD风险评分和Ann Arbor[AA 1/2]生物标志物来定义)的急性GVHD患者的初始治疗第28天时的完全缓解(CR)/部分

Blood:抑制Sirt-1可预防和缓解GVHD

中心点:Sirt-1缺陷可通过增强T细胞p53乙酰化、促进iTreg稳定性降低T细胞在GVHD中的致病性。在cGVHD发展过程中,用Sirt-1抑制剂治疗可减少Tfh产生、B细胞激活和浆细胞分化。摘要:移植物抗宿主病(GVHD)仍然是异基因骨髓造血干细胞移植(allo-BMT)的一个主要并发症。去乙酰化酶(sirt-1)在多种生理过程中发挥重要作用,如细胞衰老、代谢和炎症应答。Sirt-1去乙酰化

Blood:耗竭TCRαβ+/CD19+细胞可有效预防移植物抗宿主病(GVHD),同时降低对供体匹配度的要求

耗竭TCRαβ+/CD19+移植细胞可有效预防移植物抗宿主病(GVHD)。在本研究中,研究人员比较了原发性免疫缺陷患者(PID)移植来源于匹配的无亲缘关系的供体(MUD)和不匹配的有亲缘关系的供体(MMRDs)的造血干细胞移植(HSCT) 联合TCRαβ+/CD19+耗竭的预后。共招募了98位进行HSCT+TCRαβ+/CD19+耗竭的PIDs患儿,75位的供体为MUDs,23位的供体为MMRDs

Blood:单抗原不匹配非亲缘干细胞移植后,环磷酰胺预防GVHD的效果优于标准方法

抗胸腺细胞球蛋白(ATG)是接受不匹配非亲缘供体(MMUD)移植的患者预防移植物抗宿主(GVHD)的标准方法。近期,有报道提示移植后采用环磷酰胺(PTCY)预防具有一定安全性和可行性,但尚无研究对比PTCY和ATG用于9/10 MMUD移植预防GVHD的预后。